Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Accepts healthy volunteers Results available

A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine

ClinicalTrials.gov ID: NCT03803202

Public ClinicalTrials.gov record NCT03803202. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2, Randomized, Single Ascending Dose Study in Adults (Stage 1) and Randomized, Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, a Pneumococcal Vaccine

Study identification

NCT ID
NCT03803202
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
630 participants

Conditions and interventions

Interventions

  • ASP3772 Biological
  • PCV13 Biological
  • PPSV23 Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 23, 2019
Primary completion
Sep 27, 2020
Completion
Sep 27, 2020
Last update posted
Dec 20, 2023

2019 – 2020

United States locations

U.S. sites
26
U.S. states
11
U.S. cities
24
Facility City State ZIP Site status
Advanced Clinical Research-Rancho Paseo Banning California 92220
Artemis Institute San Diego California 92103
Artemis Institute San Marcos California 92078
Research Centers of America Hollywood Florida 33024
Meridian Clinical Research Savannah Georgia 31406
Sundance Clinical Research St Louis Missouri 63141
Meridian Clinical Research Norfolk Nebraska 68701
United Medical Associates Binghamton New York 13901
PMG Research of Raleigh Raleigh North Carolina 27604
PMG Research of Hickory, LLC Rocky Mount North Carolina 27804
Piedmont HealthCare, PA Statesville North Carolina 28625
Wilmington Health Wilmington North Carolina 28401
PMG Research of Winston-Salem, LLC Winston-Salem North Carolina 27103
Tekton Research - George Town Yukon Oklahoma 73099
PMG Research Knoxville Tennessee 37912
PMG Research Knoxville Tennessee 37938
Advanced Clinical Research Institute Cedar Park Texas 78613
Texas Healthcare, PLLC Fort Worth Texas 76104
Benchmark Research Fort Worth Texas 76135
Texas Center for Drug Development Houston Texas 77081
Healthcare Associatiates of Texas McKinney Texas 75070
DM Clinical Research Pearland Texas 77584
Benchmark Research San Angelo Texas 76904
Clinical Trials of Texas San Antonio Texas 78229
Martin Diagnostic Clinic Tomball Texas 77375
CRA of Tidewater Inc Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03803202, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 20, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03803202 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →